ind-approval | Media Room | PressRelease.com

Tagged ind-approval

Direct Biologics Announces FDA Acceptance of IND Application for a Phase I/II Clinical Trial Studying ExoFlo for Acute Respiratory Distress Syndrome

Press Release Jul 14, 2021

Direct Biologics Announces FDA Acceptance of IND Application for a Phase I/II Clinical Trial Studying ExoFlo for Acute Respiratory Distress Syndrome

Fourth IND Application approval for investigational extracellular vesicle (EV) product ExoFlo Read More

First
Prev

1

Next
Last